0000950170-24-084297.txt : 20240717 0000950170-24-084297.hdr.sgml : 20240717 20240717163011 ACCESSION NUMBER: 0000950170-24-084297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hassanein Waleed H CENTRAL INDEX KEY: 0001430466 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 241122579 MAIL ADDRESS: STREET 1: TRANSMEDICS INC STREET 2: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-07-15 0001756262 TransMedics Group, Inc. TMDX 0001430466 Hassanein Waleed H C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 true true false false President & CEO true Common Stock 2024-07-15 4 M false 8625 13.28 A 70268 D Common Stock 2024-07-15 4 S false 1397 143.61 D 68871 D Common Stock 2024-07-15 4 S false 2540 144.34 D 66331 D Common Stock 2024-07-15 4 S false 2046 145.54 D 64285 D Common Stock 2024-07-15 4 S false 2342 146.39 D 61943 D Common Stock 2024-07-15 4 S false 300 147.28 D 61643 D Common Stock 469359 I By the Waleed H. Hassanein Revocable Trust Stock Option (Right to Buy) 13.28 2024-07-15 4 M false 8625 0 D 2032-02-22 Common Stock 8625 122125 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $143.00 to $143.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $144.03 to $144.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $145.07 to $145.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $146.00 to $146.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $147.02 to $147.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-07-17